Cheers, We’ve recently released an Initiation of Coverage Report on Modulight. Modulight is a laser company focused on biomedical, medical, and life science applications. The company grew profitably during the previous decade and is now looking to get back on that track after some recent difficulties. The full report is availabe to all readers freely. Feel free to ask any questions you may have on the investment case and please remember to tag my name to avoid missing your question. -Antti, Analyst, Life Sciences Inderes — Connecting Investors and Companies Modulight: Laser company being calibrated towards growth Modulight is a technology company focused on the design and manufacture of lasers and optics with a strategic focus on medical and biomedical applications. Modulight's growth story was interrupted... Our most recent company update following Q1: Inderes — Connecting Investors and Companies Modulight: Start of the year was still difficult In connection with its business review, Modulight released key business indicators on Friday. The company's Q1’23 revenue and EBIT fell from the comparison period and were clearly below our ...

Modulights Q3-resultat var lägre än förväntat när det gäller omsättningen, även om vinsten och kassaflödet var i linje med prognoserna. Omsättningen påverkades negativt av övergången till PPT-modellen och förseningar i prototypleveranser. Utsikterna för 2024 verkar vara under målen, och rapporten visade ännu inga tecken på tillväxt. Inderes Modulight Q3'24 flash comment: Revenue missed expectations - profit and cash... Modulight's revenue was well below our expectations, but profit and cash flow were close to our forecasts. Revenue was negatively impacted by the transition to the PPT (pay-per-treatment) model and delays in prototype deliveries.

Modulights Q3-resultat under förväntningarna – intäkterna påverkades av förändringar i intäktsmodellen och leveransförseningar Modulight offentliggjorde på fredagen sitt resultat för tredje kvartalet, där intäkterna var klart lägre än förväntat. Bolagets vinst och kassaflöde motsvarade däremot prognoserna. Intäkterna påverkades negativt av övergången till PPT (pay-per-treatment)-modellen samt förseningar i prototypleveranser. Bolagets utsikter för 2024 ser ut att bli sämre än både bolagets egna och marknadens mål. En webcast hålls på måndag kl. 14.30 EEST för en närmare analys av resultatet, och vi uppdaterar våra bedömningar senast på tisdag. Hittills har rapporten inte visat några tydliga tecken på en återgång till tillväxt. Inderes Modulight Q3'24 flash comment: Revenue missed expectations - profit and cash... Modulight's revenue was well below our expectations, but profit and cash flow were close to our forecasts. Revenue was negatively impacted by the transition to the PPT (pay-per-treatment) model and delays in prototype deliveries.

Here is a high-quality and free analysis of Modylight. Inderes Modulight: 2023 landed below targets - Inderes Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company's own targets. Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company’s own targets. We are revising our forecasts for the coming years moderately downwards with the visibility being very low. With the forecast cuts, the stock still looks expensive both in absolute terms and relative to peers. In the coming year, new commercializations can give greater visibility to the company’s future.

Here is a really good analysis. “The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company’s revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in this quarter. We are lowering our estimates for the short and long term in view of the difficulties in the business and the continuing very low visibility. Despite the fall in the share price, the valuation seems even more challenging than before, as in addition to our estimates, our view on the acceptable multiples for the stock has gone down.” Inderes — Connecting Investors and Companies Modulight: Growth not picking up yet The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company's revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in...

Modulight: Positiv utveckling fortsatte, uppstarten av verksamhet på lokal nivå i USA framskred väl. Modulight Corporation Modulight, Inc.

Here’s a new analysis of Modylight for you. Inderes — Connecting Investors and Companies Modulight: Checking estimates ahead of the Q2 report Our Q2 estimates have expected strong growth from the company, based on the start of commercialization of the ophthalmic laser during Q2'23. The company has also referred to other projects with significant revenue potential in 2023. We are lowering...